Down-regulation of pro-apoptotic genes is an early event in the progression of malignant melanoma

Ann Surg Oncol. 2007 Apr;14(4):1416-23. doi: 10.1245/s10434-006-9226-2. Epub 2006 Dec 30.

Abstract

Introduction: Down-regulation of apoptosis genes has been implicated in the development and progression of malignant melanoma. We used cDNA microarray to evaluate pro-apoptotic gene expression comparing normal skin to melanoma (thin and thick), nodal disease and distant metastases.

Methods: Twenty-eight specimens including skin (n = 1), thin melanoma (n = 6), thick melanoma (n = 7), nodal disease (n = 6), and distant metastases (n = 8), were harvested at the time of resection from 16 individuals. RNA was isolated and microarray analysis utilizing the Affymetrix GeneChip (54,000 genetic elements, U133A+B... levels) was performed. Mean level of expression was calculated for each gene within a sample group. Expression profiles were then compared between tissue groups. Student's t-test was used to determine variance in expression between groups.

Results: We reviewed the expression of 54,000 genetic elements, of which 2,015 were found to have significantly altered expression. This represents 1,602 genes. Twenty-two pro-apoptotic genes were found to be down-regulated when compared to normal skin. Overall reduction was evaluated comparing normal skin to metastases with a range of 3.31-64.04-fold-decrease. When comparing the tissue types sequentially, the greatest fold-decrease in gene expression occurred when comparing skin to all melanomas (thin and thick) (p = 0.011). Subset analysis comparing normal skin to thin melanoma or thick melanoma, revealed the greatest component of overall reduction at the transition from thin to thick lesions (p = 0.003).

Conclusion: Sequential down-regulation of pro-apoptotic genes is associated with the progression of malignant melanoma. The greatest fold-decrease occurs in the transformation from thin to thick lesions.

Publication types

  • Comparative Study

MeSH terms

  • Apoptosis / genetics
  • Apoptosis Regulatory Proteins / genetics*
  • Biomarkers, Tumor / genetics*
  • Cell Transformation, Neoplastic / genetics
  • Disease Progression
  • Down-Regulation
  • Gene Expression Profiling*
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Melanoma / genetics*
  • Melanoma / metabolism
  • Melanoma / secondary
  • Oligonucleotide Array Sequence Analysis
  • RNA, Neoplasm / genetics
  • RNA, Neoplasm / metabolism
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / secondary

Substances

  • Apoptosis Regulatory Proteins
  • Biomarkers, Tumor
  • RNA, Neoplasm